← Back to Search

Toviaz (Fesoterodine) for Urinary Retention (Toviaz Trial)

Phase 4
Waitlist Available
Led By Alexis Te, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients will be selected by the investigator and sub-investigator's patient population, and physician referrals. All patients will meet the inclusion/
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up screening (month 0), 2-months, 3-months, 7-months
Awards & highlights
All Individual Drugs Already Approved
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial

Summary

The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency with or without the inability to hold your urine until you get to the toilet) are invited to participate in this research study.

Eligible Conditions
  • Urinary Retention

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening (month 0), 2-months, 3-months, 7-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and screening (month 0), 2-months, 3-months, 7-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Average Flow Rate (Qavg)
IPSS Irritative
IPSS Nocturia
+4 more

Side effects data

From 2013 Phase 4 trial • 17 Patients • NCT00605319
18%
Constipation/Dry Mouth
12%
Urinary Leakage
6%
Nausea/Vomiting
100%
80%
60%
40%
20%
0%
Study treatment Arm
Toviaz (Fesoterodine)

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Toviaz (Fesoterodine)Experimental Treatment1 Intervention
Toviaz 4mg to 8mg
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fesoterodine
FDA approved

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,082 Previous Clinical Trials
1,138,142 Total Patients Enrolled
PfizerIndustry Sponsor
4,647 Previous Clinical Trials
17,743,558 Total Patients Enrolled
Alexis Te, MDPrincipal InvestigatorCornell University
1 Previous Clinical Trials
20 Total Patients Enrolled
~1 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top